RB
Vicarious Surgical Inc. WT
RBOT-WT · NYSE
$0.01 -24.77% (-$0.00)
Market Cap $14.2M
P/E Ratio -
Div. Yield -
ROE 181.79%
Bulios Fair Price
$0.01
22.0% upside
Current Price
$0.0082
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RBOT-WT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
58 /100
Fair P/S 6.77x
P/B 1.01x
P/E N/A
Growth
100 /100
Growing Book val. growth 92.23%
EPS growth N/A
Rev. growth N/A
Profitability
13 /100
Weak Gross margin 33.16%
Net margin 2,564.26%
Op. margin 2,667.32%
Quality
1 /100
Poor ROIC 202.52%
ROE 181.79%
ROA 182.62%
Debt
83 /100
Low Debt/Equity 0.91x
Current ratio 4.75x
Net debt/EBITDA -0.18x
Stability
12 /100
Unstable Beta 1.52x
EPS volatility 157.93%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RBOT-WT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Adam David Sachs
Employees
123
Headquarters
Waltham